Table 2 Market shares and their CAGRs, for the eight countries, from 2010 to 2017
From: An analysis of orphan medicine expenditure in Europe: is it sustainable?
| Â | Market share (%) | |||||
|---|---|---|---|---|---|---|
Value | Volume | |||||
| Â | 2010 | 2017 | CAGR | 2010 | 2017 | CAGR |
Orphan | 3.1 | 7.2 | 13 | < 0.1 | < 0.1 | 11 |
Non-Orphan Branded | 62.4 | 57.3 | -1 | 27.6 | 22.6 | -3 |
Unbranded | 28.2 | 30.0 | 1 | 52.4 | 58.1 | 1 |
Other Expendituresa | 6.3 | 5.5 | -2 | 20.0 | 19.3 | -1 |